Insider Trading & Ownership of Thomas Malley

Location: Hamilton, Bermuda
Summary: The estimated net worth of Thomas Malley is at least $17.5M dollars as of 14 Aug 2025. Thomas Malley is the Director of BeiGene, Ltd. and owns shares of BeiGene, Ltd. (ONC) stock worth about $15.1M. Thomas Malley is the Director of Kiniksa Pharmaceuticals International, plc and owns shares of Kiniksa Pharmaceuticals International, plc (KNSA) stock worth about $2.39M.
Signature: /s/ Madelyn Zeylikman, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Thomas Malley files a new Insider Trading report.

Ownership of Thomas Malley

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ONC, BEIGF	BeiGene, Ltd.	Director	$15.1M			15 Jun 2023
KNSA	Kiniksa Pharmaceuticals International, plc	Director	$2.39M	-$5.86M	-71%	12 Aug 2025
KURA	Kura Oncology, Inc.	Director				05 Jun 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.